Leases

3 Months Ended

Sep. 25, 2021

7. Leases

Our leases mainly include our worldwide office and research and development facilities which are all classified as operating leases. Certain leases include renewal options that are under our discretion. The leases expire at various dates through fiscal year 2029, some of which include options to extend the lease for up to 5 years. For the three months ended September 25, 2021 and September 26, 2020, we recorded approximately $2.8 million and $2.4 million, respectively, of operating leases expense. Our short-term leases are immaterial.

As of September 25, 2021, and June 26, 2021, the components of leases and lease costs are as follows (in millions):


	September		June
	2021		2021
Operating lease right-of-use assets	$	35.9	$	31.7
Operating lease liabilities	$	8.9	$	9.3
Operating lease liabilities, long-term		28.0		24.0
Total operating lease liabilities	$	36.9	$	33.3

Supplemental cash flow information related to leases is as follows (in millions):


	Three Months Ended
	September
	2021		2020
Cash paid for operating leases included in operating cash flows	$	3.0	$	1.9
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets		6.6		1.8

As of September 25, 2021, the weighted average remaining lease term is 5.9 years, and the weighted average discount rate is 3.8%.

Future minimum lease payments for the operating lease liabilities are as follows (in millions):


	Operating
	Lease
Fiscal Year	Payments
Remainder of 2022	$	7.8
2023		7.1
2024		6.4
2025		5.1
2026		4.9
Thereafter		9.9
Total future minimum operating lease payments		41.2
Less: interest		(4.3	)
Total lease liabilities	$	36.9